Inhaled nitric oxide alters the distribution of blood flow in the healthy human lung, suggesting active hypoxic pulmonary vasoconstriction in normoxia

Journal of Applied Physiology

Volumn 118, Issue 3, 2015, Pages 331-343

  Asadi, Amran K ^a   Sá, Rui Carlos ^a   Kim, Nick H ^a   Theilmann, Rebecca J ^b   Hopkins, Susan R ^a,b   Buxton, Richard B ^b   Prisk, G Kim ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arterial spin labeling; Hypoxic pulmonary vasoconstriction; MRI; Nitric oxide; Pulmonary blood flow

Indexed keywords

NITRIC OXIDE; SPIN LABEL;

ADULT; ANOXIA; BLOOD FLOW; DRUG EFFECTS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG CIRCULATION; MALE; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; PROCEDURES; SPIN LABELS; VASOCONSTRICTION; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADULT; ANOXIA; HUMANS; LUNG; MALE; NITRIC OXIDE; PERFUSION; PULMONARY CIRCULATION; REGIONAL BLOOD FLOW; SPIN LABELS; VASOCONSTRICTION; YOUNG ADULT;

EID: 84922370060     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01354.2013     Document Type: Article

References (47)

1. Adnot S, Raffestin B, Eddahibi S. NO in the lung. Respir Physiol 101: 109-120, 1995.
2. Arai TJ, Henderson AC, Dubowitz DJ, Levin DL, Friedman PJ, Buxton RB, Prisk GK, Hopkins SR. Hypoxic pulmonary vasoconstriction does not contribute to pulmonary blood flow heterogeneity in normoxia in normal supine humans. J Appl Physiol 106: 1057-1064, 2009.
3. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charyb-dotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91: 7583-7587, 1994.
4. Archer SL, Tolins JP, Raij L, Weir EK. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun 164: 1198-1205, 1989.
5. O2. J Appl Physiol 114: 107-118, 2013.
6. Barer GR, Howard P, Shaw JW. Stimulus-response curves for the pulmonary vascular bed to hypoxia and hypercapnia. J Physiol 211: 139-155, 1970.
7. Bolar DS, Levin DL, Hopkins SR, Frank LF, Liu TT, Wong EC, Buxton RB. Quantification of regional pulmonary blood flow using ASL-FAIRER. Magn Reson Med 55: 1308-1317, 2006.
8. Burrowes KS, Buxton RB, Prisk GK. Assessing potential errors of MRI-based measurements of pulmonary blood flow using a detailed network flow model. J Appl Physiol 113: 130-141, 2012.
9. Carey MA, Card JW, Voltz JW, Arbes SJ Jr, Germolec DR, Korach KS, Zeldin DC. It's all about sex: gender, lung development and lung disease. Trends Endocrinol Metab 18: 308-313, 2007.
10. Croft QPP, Formenti F, Talbot NP, Lunn D, Robbins PA, Dorrington KL. Variations in alveolar partial pressure for carbon dioxide and oxygen have additive not synergistic acute effects on human pulmonary vasoconstriction. PLos One 8: e67886, 2013.
11. Dohi Y, Kojima M, Sato K, Lüscher T. Age-related changes in vascular smooth muscle and endothelium. Drugs Aging 7: 278-291, 1995.
12. Euler USV, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 12: 301-320, 1946.
13. Fishman AP. Acute hypoxia and pulmonary vasoconstriction in humans: uncovering the mechanism of the pressor response. Am J Physiol Lung Cell Mol Physiol 287: L893-L894, 2004.
14. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78: 427-435, 1993.
15. Galiè N, Seeger W, Naeije R, Simonneau G, Rubin LJ. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 43: S81-S88, 2004.
16. Glenny RW, Robertson HT, Hlastala MP. Vasomotor tone does not affect perfusion heterogeneity and gas exchange in normal primate lungs during normoxia. J Appl Physiol 89: 2263-2267, 2000.
17. Glenny RW, Robertson HT. Spatial Distribution of Ventilation and Perfusion: Mechanisms and Regulation. In: Comprehensive Physiology. Hoboken, NJ: Wiley, 2011, p. 16-30.
18. Grant BJ, Davies EE, Jones HA, Hughes JM. Local regulation of pulmonary blood flow and ventilation-perfusion ratios in the coatimundi. J Appl Physiol 40: 216-228, 1976.
19. Hayward CS, Kalnins WV, Rogers P, Feneley MP, Macdonald PS, Kelly RP. Effect of inhaled nitric oxide on normal human left ventricular function. J Am Coll Cardiol 30: 49-56, 1997.
20. Henderson AC, Prisk GK, Levin DL, Hopkins SR, Buxton RB. Characterizing pulmonary blood flow distribution measured using arterial spin labeling. NMR Biomed 22: 1025-1035, 2009.
21. Henderson AC, Sá RC, Theilmann RJ, Buxton RB, Prisk GK, Hopkins SR. The gravitational distribution of ventilation-perfusion ratio is more uniform in prone than supine posture in the normal human lung. J Appl Physiol 115: 313-324, 2013.
22. Hermansen L, Ekblom B, Saltin B. Cardiac output during submaximal and maximal treadmill and bicycle exercise. J Appl Physiol 29: 82-86, 1970.
23. Hopkins SR, Arai TJ, Henderson AC, Levin DL, Buxton RB, Prisk GK. Lung volume does not alter the distribution of pulmonary perfusion in dependent lung in supine humans. J Physiol 588: 4759-4768, 2010.
24. Hopkins SR, Prisk GK. Lung perfusion measured using magnetic resonance imaging: new tools for physiological insights into the pulmonary circulation. J Magn Reson Imaging 32: 1287-1301, 2010.
25. Högman M, Frostell CG, Hedenström H, Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 148: 1474-1478, 1993.
26. Jolliet P, Bulpa P, Thorens JB, Ritz M, Chevrolet JC. Nitric oxide and prostacyclin as test agents of vasoreactivity in severe precapillary pulmonary hypertension: predictive ability and consequences on haemodynamics and gas exchange. Thorax 52: 369-372, 1997.
27. Joyce CJ, Baker AB, Kennedy RR. Gas uptake from an unventilated area of lung: computer model of absorption atelectasis. J Appl Physiol 74: 1107-1116, 1993.
28. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 92: 99-104, 1993.
29. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 34: 888-894, 2009.
30. Martin MA. Bootstrap hypothesis testing for some common statistical problems: a critical evaluation of size and power properties. Comput Stat Data Analysis 51: 6321-6342, 2007.
31. Mélot C, Naeije R, Hallemans R, Lejeune P, Mols P. Hypoxic pulmonary vasoconstriction and pulmonary gas exchange in normal man. Respir Physiol 68: 11-27, 1987.
32. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, pharmacology. Pharmacol Rev 43: 109-142, 1991.
33. Motley HL, Cournand A, Werko L, Himmelstein A, Dresdale D. The influence of short periods of induced acute anoxia upon pulmonary artery pressures in man. Am J Physiol 150: 315-320, 1947.
34. Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol 98: 390-403, 2005.
35. Naeije R, Brimioulle S. Physiology in medicine: importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure. Crit Care 5: 67-71, 2001.
36. Naeije R, Mols P, Hallemans R, Mélot C. Effects of vasodilators on hypoxic pulmonary vasoconstriction in normal man. Chest 82: 404-410, 1982.
37. Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, Falke KJ. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 74: 1287-1292, 1993.
38. Prisk GK, Yamada K, Henderson AC, Arai TJ, Levin DL, Buxton RB, Hopkins SR. Pulmonary perfusion in the prone and supine postures in the normal human lung. J Appl Physiol 103: 883-894, 2007.
39. Rahn H, Bahnson HT. Effect of unilateral hypoxia on gas exchange and calculated pulmonary blood flow in each lung. J Appl Physiol 6: 105-112, 1953.
40. Rich GF, Murphy GDJ, Roos CM, Johns RA. Inhaled nitric oxide: selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 78, 1993.
41. Silvennoinen MJ, Kettunen MI, Kauppinen RA. Effects of hematocrit and oxygen saturation level on blood spin-lattice relaxation. Magn Reson Med 49: 568-571, 2003.
42. Sitbon O, Brenot F, Denjean A, Bergeron A, Parent F, Azarian R, Herve P, Raffestin B, Simonneau G. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 151: 384-389, 1995.
43. Spees WM, Yablonskiy DA, Oswood MC, Ackerman JJH. Water proton MR properties of human blood at 1.5 Tesla: Magnetic susceptibility, T1, T2, T&z.ast;2, and non-Lorentzian signal behavior. Magn Reson Med 45: 533-542, 2001.
44. Sylvester JT, Shimoda LA, Aaronson PI, Ward JP. Hypoxic pulmonary vasoconstriction. Physiol Rev 92: 367-520, 2012.
45. 2. J Appl Physiol 15: 405-410, 1960.
46. West JB, Mathieu-Costello O. Vulnerability of pulmonary capillaries in heart disease. Circulation 92: 622-631, 1995.
47. West JB, Wagner PD. Bioengineering aspects of the lung. In: Lung Biology in Health and Disease, edited by West JB. New York: Dekker, 1977, vol 3.